%PDF-1.4
%
1 0 obj
<>stream
application/pdf
10.1080/1744666X.2019.1587294
en
Avatrombopag for the treatment of immune thrombocytopenia
Monika Długosz-Danecka
Joanna Zdziarska
Wojciech Jurczak
Taylor & Francis
Expert Review of Clinical Immunology, 2019. doi:10.1080/1744666X.2019.1587294
Avatrombopag
clinical trials
TPO-RA
eltrombopag
ITP
CLD
thrombocytopenia
platelet transfusion
pharmacokinetics
pharmacodynamics
Journal
Expert Review of Clinical Immunology
© 2019 Informa UK Limited, trading as Taylor & Francis Group
1744-666X
1744-8409
15
4
327
339
10.1080/1744666X.2019.1587294
https://doi.org/10.1080/1744666X.2019.1587294
VoR
2019-03-08T23:45:59+05:30
Arbortext Advanced Print Publisher 11.0.3433/W Unicode
2019-03-20T14:52:34-07:00
2019-03-20T14:52:34-07:00
Avatrombopag; clinical trials; TPO-RA; eltrombopag; ITP; CLD; thrombocytopenia; platelet transfusion; pharmacokinetics; pharmacodynamics
iText 4.2.0 by 1T3XT
uuid:6bc2c0cb-9849-43dc-81c7-33c4913bca31
uuid:948fcd4d-4e0f-4a44-9f46-69bb737a4083
2019-02-25truewww.tandfonline.com10.1080/1744666X.2019.1587294www.tandfonline.comtrue2019-02-2510.1080/1744666X.2019.1587294
endstream
endobj
4 0 obj
<>stream
xYI7S)KF h$;'
dxqNlr)7*
GJGXl0??>H3.,䐖~:?C2<6X Z-uw|,~Ib|6,<_7n.Ү2NO81Fa1H3Ӹ_wZ]bFUMp;(P`ؚ?k{0͞EP蛕{m̲K٩v|YB۷&s=-iYB[?JoOczch]5Cnq.֚ͳ.]iӭ?Sӟ'"nm-b)>9bdv~)RO#q>-(ggY;("j"VzUdEscU l\\
]Rud `|8